Last 12 months
Inside the activity.
5 purchase rows · 8 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 4 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 1 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 1 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 30, 2017 Filed Dec 1, 2017 23:46 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 700 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-014791 · edgar.xml · derivative · entry 9 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,082 Underlying: Common Stock · 700 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 23:46 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 700 | $44.50 | $31,150.00 |
DisclosureSEC source: 0001179110-17-014791 · edgar.xml · nonDerivative · entry 7 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 Read SEC document |
| November 30, 2017 Filed Dec 1, 2017 23:46 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 700 | $13.75 | $9,625.00 |
DisclosureSEC source: 0001179110-17-014791 · edgar.xml · nonDerivative · entry 6 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,234 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 23:46 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 2,218 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-014791 · edgar.xml · derivative · entry 8 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,782 Underlying: Common Stock · 2,218 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 23:46 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 2,218 | $44.57 | $98,856.26 |
DisclosureSEC source: 0001179110-17-014791 · edgar.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.50 to $44.70, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| November 29, 2017 Filed Dec 1, 2017 23:46 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 2,218 | $13.75 | $30,497.50 |
DisclosureSEC source: 0001179110-17-014791 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,752 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 19:26 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 670 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-012359 · edgar.xml · derivative · entry 6 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,000 Underlying: Common Stock · 670 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 19:26 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 670 | $42.06 | $28,179.53 |
DisclosureSEC source: 0001179110-17-012359 · edgar.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to 42.15, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 14, 2017 Filed Sep 18, 2017 19:26 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 670 | $13.75 | $9,212.50 |
DisclosureSEC source: 0001179110-17-012359 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 412,204 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 21:58 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,930 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-012269 · edgar.xml · derivative · entry 6 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 54,670 Underlying: Common Stock · 1,930 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 21:58 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 1,930 | $42.02 | $81,100.53 |
DisclosureSEC source: 0001179110-17-012269 · edgar.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to 42.05, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| September 11, 2017 Filed Sep 13, 2017 21:58 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 1,930 | $13.75 | $26,537.50 |
DisclosureSEC source: 0001179110-17-012269 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,464 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:53 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 2,300 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-011287 · edgar.xml · derivative · entry 9 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,600 Underlying: Common Stock · 2,300 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:53 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 2,300 | $42.50 | $97,750.00 |
DisclosureSEC source: 0001179110-17-011287 · edgar.xml · nonDerivative · entry 7 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 Read SEC document |
| August 08, 2017 Filed Aug 9, 2017 20:53 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 2,300 | $13.75 | $31,625.00 |
DisclosureSEC source: 0001179110-17-011287 · edgar.xml · nonDerivative · entry 6 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 413,834 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · derivative · entry 11 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2023-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/26/2017. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 10,000 | $0.00 Strike: $20.27 | $0.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · derivative · entry 10 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 10,000 shares Expires 2022-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2016. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 1,000 | $0.00 Strike: $13.99 | $0.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · derivative · entry 9 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 1,000 shares Expires 2021-06-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 06/11/2015. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · derivative · entry 8 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/22/2014. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,000 | $0.00 Strike: $12.91 | $0.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · derivative · entry 7 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 4,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 05/23/2013. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
SaleCommon Stock, No Par Value | 25,000 | $41.15 | $1,028,750.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · nonDerivative · entry 6 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,400 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.10 to 41.25, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $18.80 | $94,000.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · nonDerivative · entry 5 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 10,000 | $20.27 | $202,700.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · nonDerivative · entry 4 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 1,000 | $13.99 | $13,990.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · nonDerivative · entry 3 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $9.95 | $49,750.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · nonDerivative · entry 2 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 8, 2017 21:22 UTC |
ANDERSON A SCOTTDirector
|
Exercise / conversionCommon Stock, No Par Value | 4,000 | $12.91 | $51,640.00 |
DisclosureSEC source: 0001179110-17-011237 · edgar.xml · nonDerivative · entry 1 ANDERSON A SCOTT · CIK 0001184825 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,400 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 20:53 UTC |
STANGER KENT WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,100 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-011287 · edgar.xml · derivative · entry 8 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 58,900 Underlying: Common Stock · 5,100 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 20:53 UTC |
STANGER KENT WDirector
|
SaleCommon Stock, No Par Value | 5,100 | $42.09 | $214,659.00 |
DisclosureSEC source: 0001179110-17-011287 · edgar.xml · nonDerivative · entry 5 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 411,534 F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to 42.50, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 07, 2017 Filed Aug 9, 2017 20:53 UTC |
STANGER KENT WDirector
|
Exercise / conversionCommon Stock, No Par Value | 5,100 | $13.75 | $70,125.00 |
DisclosureSEC source: 0001179110-17-011287 · edgar.xml · nonDerivative · entry 4 STANGER KENT W · CIK 0000901531 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 416,634 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 19:28 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,247 | $0.00 Strike: $21.98 | $0.00 |
DisclosureSEC source: 0001179110-17-011190 · edgar.xml · derivative · entry 3 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,739 Underlying: Common Stock · 4,247 shares Expires 2022-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 7/16/2016. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 19:28 UTC |
Millner F. Ann Ed.D.Director
|
SaleCommon Stock, No Par Value | 3,106 | $41.01 | $127,389.48 |
DisclosureSEC source: 0001179110-17-011190 · edgar.xml · nonDerivative · entry 2 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,644 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.005 to 41.05, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 03, 2017 Filed Aug 7, 2017 19:28 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 4,247 | $21.98 | $93,349.06 |
DisclosureSEC source: 0001179110-17-011190 · edgar.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,750 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 23:22 UTC |
EDELMAN RICHARD WSee Footnote (1)
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $13.75 | $0.00 |
DisclosureSEC source: 0001179110-17-010914 · edgar.xml · derivative · entry 3 EDELMAN RICHARD W · CIK 0001184931 · See Footnote (1) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2018-08-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 08/11/2012. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 23:22 UTC |
EDELMAN RICHARD WSee Footnote (1)
|
SaleCommon Stock, No Par Value | 29,000 | $41.19 | $1,194,597.00 |
DisclosureSEC source: 0001179110-17-010914 · edgar.xml · nonDerivative · entry 2 EDELMAN RICHARD W · CIK 0001184931 · See Footnote (1) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,000 F1 · date: The reporting person ceased to be a director of the Issuer on May 24, 2017. F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.10 to 41.25, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| August 01, 2017 Filed Aug 1, 2017 23:22 UTC |
EDELMAN RICHARD WSee Footnote (1)
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $13.75 | $275,000.00 |
DisclosureSEC source: 0001179110-17-010914 · edgar.xml · nonDerivative · entry 1 EDELMAN RICHARD W · CIK 0001184931 · See Footnote (1) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The reporting person ceased to be a director of the Issuer on May 24, 2017. Read SEC document |
| June 30, 2017 Filed Jul 6, 2017 00:11 UTC |
EDELMAN RICHARD WSee Footnote (1)
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 20,000 | $0.00 Strike: $9.95 | $0.00 |
DisclosureSEC source: 0001179110-17-010115 · edgar.xml · derivative · entry 5 EDELMAN RICHARD W · CIK 0001184931 · See Footnote (1) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 20,000 shares Expires 2020-05-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 05/22/2014. Installments scheduled for vesting after 5/22/2017 will not be exercisable. Read SEC document |
| June 30, 2017 Filed Jul 6, 2017 00:11 UTC |
EDELMAN RICHARD WSee Footnote (1)
|
SaleCommon Stock, No Par Value | 20,000 | $37.62 | $752,380.00 |
DisclosureSEC source: 0001179110-17-010115 · edgar.xml · nonDerivative · entry 2 EDELMAN RICHARD W · CIK 0001184931 · See Footnote (1) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · date: The reporting person ceased to be a director of the Issuer on May 24, 2017. F2 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.53 to 37.80, inclusive. The reporting person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 30, 2017 Filed Jul 6, 2017 00:11 UTC |
EDELMAN RICHARD WSee Footnote (1)
|
Exercise / conversionCommon Stock, No Par Value | 20,000 | $9.95 | $199,000.00 |
DisclosureSEC source: 0001179110-17-010115 · edgar.xml · nonDerivative · entry 1 EDELMAN RICHARD W · CIK 0001184931 · See Footnote (1) 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The reporting person ceased to be a director of the Issuer on May 24, 2017. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 20:54 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 5,000 | $0.00 Strike: $18.80 | $0.00 |
DisclosureSEC source: 0001179110-17-009778 · edgar.xml · derivative · entry 5 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,000 Underlying: Common Stock · 5,000 shares Expires 2023-05-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/26/2017. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 20:54 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 4,247 | $0.00 Strike: $21.98 | $0.00 |
DisclosureSEC source: 0001179110-17-009778 · edgar.xml · derivative · entry 4 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,986 Underlying: Common Stock · 4,247 shares Expires 2022-07-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 7/16/2016. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 20:54 UTC |
Millner F. Ann Ed.D.Director
|
SaleCommon Stock, No Par Value | 6,744 | $38.15 | $257,297.09 |
DisclosureSEC source: 0001179110-17-009778 · edgar.xml · nonDerivative · entry 3 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,503 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.00 to 38.33, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 20:54 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 5,000 | $18.80 | $94,000.00 |
DisclosureSEC source: 0001179110-17-009778 · edgar.xml · nonDerivative · entry 2 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 28, 2017 Filed Jun 29, 2017 20:54 UTC |
Millner F. Ann Ed.D.Director
|
Exercise / conversionCommon Stock, No Par Value | 4,247 | $21.98 | $93,349.06 |
DisclosureSEC source: 0001179110-17-009778 · edgar.xml · nonDerivative · entry 1 Millner F. Ann · CIK 0001649014 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,247 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 16:26 UTC |
Karras Nolan E.Director
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 8,000 | $0.00 Strike: $12.91 | $0.00 |
DisclosureSEC source: 0001179110-17-009755 · edgar.xml · derivative · entry 5 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 8,000 shares Expires 2019-05-23 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/23/2013. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 16:26 UTC |
Karras Nolan E.Director
|
SaleCommon Stock, No Par Value | 7,000 | $37.15 | $260,057.00 |
DisclosureSEC source: 0001179110-17-009755 · edgar.xml · nonDerivative · entry 4 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 F1 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $37.150 to 37.155, inclusive. The reporting person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. F2 · ownership.direct: Shares held jointly by the reporting person and his spouse. Read SEC document |
| June 27, 2017 Filed Jun 29, 2017 16:26 UTC |
Karras Nolan E.Director
|
Exercise / conversionCommon Stock, No Par Value | 8,000 | $12.91 | $103,280.00 |
DisclosureSEC source: 0001179110-17-009755 · edgar.xml · nonDerivative · entry 3 Karras Nolan E. · CIK 0001534914 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:50 UTC |
EDELMAN RICHARD WDirector
|
Exercise / conversionNon-qualified stock options (right to buy) · Derivative | 13,379 | $0.00 Strike: $13.16 | $0.00 |
DisclosureSEC source: 0001179110-17-008141 · edgar.xml · derivative · entry 6 EDELMAN RICHARD W · CIK 0001184931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 13,379 shares Expires 2017-06-25 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: Became exercisable in equal annual installments of 20% commencing 06/25/2011. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:50 UTC |
EDELMAN RICHARD WDirector
|
SaleCommon Stock, No Par Value | 8,563 | $34.42 | $294,738.46 |
DisclosureSEC source: 0001179110-17-008141 · edgar.xml · nonDerivative · entry 4 EDELMAN RICHARD W · CIK 0001184931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 F1 · date: The Reporting Person ceased to be a director of the Issuer on March 24, 2017. F3 · shares: The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 8,563 of such shares to pay the exercise price and taxes and issuing the remaining 4,816 shares to the Reporting Person. F4 · price: The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $34.40 to 34.50, inclusive. The Reporting Person undertakes to provide to Issuer, any security holder of Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4. Read SEC document |
| May 25, 2017 Filed May 26, 2017 20:50 UTC |
EDELMAN RICHARD WDirector
|
Exercise / conversionCommon Stock, No Par Value | 13,379 | $13.16 | $176,067.64 |
DisclosureSEC source: 0001179110-17-008141 · edgar.xml · nonDerivative · entry 3 EDELMAN RICHARD W · CIK 0001184931 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,563 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · date: The Reporting Person ceased to be a director of the Issuer on March 24, 2017. F3 · shares: The Reporting Person paid the exercise price on a cashless basis, resulting in the Issuer's withholding of 8,563 of such shares to pay the exercise price and taxes and issuing the remaining 4,816 shares to the Reporting Person. Read SEC document |
| May 24, 2017 Filed May 26, 2017 20:48 UTC |
LIU DAVID MING-TEHDirector
|
GrantNon-qualified stock options (right to buy) · Derivative | 25,000 | $0.00 Strike: $34.40 | $0.00 |
DisclosureSEC source: 0001179110-17-008139 · edgar.xml · derivative · entry 2 LIU DAVID MING-TEH · CIK 0001680776 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common stock · 25,000 shares Expires 2024-05-24 F2 · derivative.exercise_date: Becomes exercisable in equal annual installments of 20% commencing 5/24/2018. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.